Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model.

Drug Des Devel Ther · 2015 · PMC4408966 · PMID 25945036

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

10 Despite the clear benefits of CD34s, recent randomized, controlled trials found that the Genous stent showed a trend of higher rates of target vessel failure.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.